Clinical Trials Directory

Trials / Completed

CompletedNCT06091800

Interleukin 20 and Periodontal Tisuue Destruction

Determination of Levels of IL-20, TNF-α, IL1β/IL-10, RANKL/OPG and MMP8 in Serum and Gingival Crevicular Fluid (GCF) in Peridontally Healthy and Periodontitis Individuals

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Recep Tayyip Erdogan University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

Periodontitis is an inflammatory disease that causes destruction of periodontal tissues. IL-20, on the other hand, is known as a potent angiogenic, chemotactic, and pro-inflammatory cytokine associated with various chronic inflammatory disorders. IL-20 has a significant role in the regulation of osteoclastogenesis and osteoblastogenesis. The aim of this study was to evaluate the effect of IL-20 on periodontal destruction. In the study, a total of 60 participants were included, 30 of whom were systemically and periodontally healthy (control group) and 30 of whom were systemically healthy and had periodontitis (periodontitis group). GCF and serum samples were collected from the participants for biochemical analysis. ELISA method was used to determine IL-20, TNF-α, IL1β/IL-10, RANKL/OPG and MMP8 levels

Conditions

Interventions

TypeNameDescription
OTHERbiochemical analysisGCF and serum samples were collected from the participants for biochemical analysis.

Timeline

Start date
2022-06-06
Primary completion
2023-03-06
Completion
2023-06-06
First posted
2023-10-19
Last updated
2023-10-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06091800. Inclusion in this directory is not an endorsement.